Table 1

Demographic and clinical characteristics of 15 582 patients diagnosed as having lung cancer between 2006 and 2008 by socioeconomic quintile

Q1 (affluent), N (%)Q2, N (%)Q3, N (%)Q4, N (%)Q5 (deprived), N (%)Total, N (%)Test
χ2 (df)p Value
All patients2111 (100)2550 (100)3035 (100)3817 (100)4069 (100)15 582 (100)
Sex
 Male1208 (57.2)1458 (57.2)1708 (56.3)2165 (56.7)2358 (58)8897 (57.1)
 Female903 (42.8)1092 (42.8)1327 (43.7)1652 (43.3)1711 (42)6685 (42.9)0.31 (1)0.57
Age at diagnosis
 0–59310 (14.7)329 (12.9)430 (14.2)637 (16.7)752 (18.5)2458 (15.8)
 60–69497 (23.5)617 (24.2)743 (24.5)990 (25.9)1086 (26.7)3933 (25.2)
 70–79751 (35.6)869 (34.1)1009 (33.2)1241 (32.5)1302 (32)5172 (33.2)
 80+553 (26.2)735 (28.8)853 (28.1)949 (24.9)929 (22.8)4019 (25.8)66.7 (1)<0.01
Charlson Score
 0897 (49.8)1065 (47.5)1217 (45.5)1496 (43.8)1494 (41.1)6169 (44.8)
 1476 (26.4)621 (27.7)754 (28.2)942 (27.6)1064 (29.3)3857 (28)
 2+428 (23.8)555 (24.8)704 (26.3)981 (28.7)1075 (29.6)3743 (27.2)53.8 (1)<0.01
 Missing310 (–)309 (–)360 (–)398 (–)436 (–)1813 (–)
Histologic type
 NSCLC961 (45.5)1058 (41.5)1236 (40.7)1515 (39.7)1623 (39.9)6393 (41)
 Other specified39 (1.8)47 (1.8)54 (1.8)61 (1.6)60 (1.5)261 (1.7)
 SCLC197 (9.3)259 (10.2)311 (10.2)440 (11.5)485 (11.9)1692 (10.9)
 Unspecified914 (43.3)1186 (46.5)1434 (47.2)1801 (47.2)1901 (46.7)7236 (46.4)27.4 (12)<0.01
Stage at diagnosis
 IA–IIB236 (15.4)341 (18.6)369 (16.9)492 (17.9)480 (15.8)1918 (16.9)
 IIIA–IV1296 (84.6)1496 (81.4)1812 (83.1)2250 (82.1)2556 (84.2)9410 (83.1)0.18 (1)0.67
 Unknown579 (–)713 (–)854 (–)1075 (–)1033 (–)4254 (–)